Floatz logo

LENVATINIB

Malignant Neoplasms of Bone and Articular Cartilage

M.D. Anderson Cancer CenterSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Malignant Neoplasms of Bone and Articular Cartilage cohort.

Asset / SponsorPhaseRating
Captopril
Children's Cancer Hospital Egypt 57357
Phase 3BB
Inno-206
Actuate Therapeutics Inc.
Phase 2B
Irinotecan
Actuate Therapeutics Inc.
Phase 2B
Angiotensin-(1-7)
Wake Forest University Health Sciences
Phase 2CCC
Enbrel
The University of Texas Health Science Center at San Antonio
Phase 2/3CCC

View all 19 →

Same molecule, other indications

LENVATINIB is also rated in:

Primary Peritoneal Cavity CancerDormant
BBB
Indicative ·
73 / 100
View asset →
Stage IIB Breast CancerDormant
BBB
Indicative ·
73 / 100
View asset →
portal vein thrombosisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →